A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered DAA-I in Healthy Subjects

NCT02666196 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: DAA-I
DRUG: Placebo

Sponsor

National University Hospital, Singapore